author-photo

Xiaofei Huang

China Pharmaceutical University

5

Papers

18

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

A new therapeutic effect of fenofibrate in Duchenne muscular dystrophy: The promotion of myostatin degradation.

2021 British Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy.

2020 Journal of Cachexia, Sarcopenia and Muscle
Show All
- Source
- Cite
- Save
Citations (4)
A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1.

2020 Journal of Cachexia, Sarcopenia and Muscle
Show All
- Source
- Cite
- Save
Citations (9)
Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway.

2020 Acta Pharmacologica Sinica
Show All
- Source
- Cite
- Save
Citations (2)